VINERGY RESOURCES/MJ BIOPHARMA ANNOUNCES BREAKTHROUGH IN ORAL CANNABINOID STRIP AND TIME RELEASE CAPSULE TECHNOLOGIES
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 14, 2017) - Vinergy Resources Ltd. (“Vinergy” or the “Company”)(CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce a major breakthrough while conducting research and development on oral cannabinoid complex (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN) and Terpenes) delivery strips and controlled time release capsule technology. This novel approach will be the basis for several products where water or saliva is the catalyst used to activate the carrier for delivery and absorption of the cannabinoid complex into the body.
This unique approach forms the basis for a fundamentally new technology and product category. The technology is called “BURST” due to its incredibly fast action and ability to enhance the body’s absorption of various medicinal ingredients contained in the Company’s products. The BURST system is built on natural botanical polymers delivering specially processed high purity cannabinoid complexes.
The unique system for cannabinoid activation maintains the natural balance of THC, CBD, CBN and terpenes while preserving the maximum therapeutic effect and potentially delivering it to the body faster than any currently available delivery method.
The patent pending technology allows for a more complete palatable drug delivery system that is effective and enhances the patient or user experience while intensifying flavour.
“This is a great breakthrough for us and the product line we have planned. The technology can also be utilized in our time release capsules which of course will have a slower absorption rate. We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma. “We look forward to providing additional updates in the coming weeks,” added Mr. Deuters.
The Hemp Business Journal estimates the total U.S. CBD market will grow to $2.1 billion in consumer sales by 2020.
Read more at http://www.stockhouse.com/companies/bullboard...eTmjvBQ.99
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 14, 2017) - Vinergy Resources Ltd. (“Vinergy” or the “Company”)(CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce a major breakthrough while conducting research and development on oral cannabinoid complex (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN) and Terpenes) delivery strips and controlled time release capsule technology. This novel approach will be the basis for several products where water or saliva is the catalyst used to activate the carrier for delivery and absorption of the cannabinoid complex into the body.
This unique approach forms the basis for a fundamentally new technology and product category. The technology is called “BURST” due to its incredibly fast action and ability to enhance the body’s absorption of various medicinal ingredients contained in the Company’s products. The BURST system is built on natural botanical polymers delivering specially processed high purity cannabinoid complexes.
The unique system for cannabinoid activation maintains the natural balance of THC, CBD, CBN and terpenes while preserving the maximum therapeutic effect and potentially delivering it to the body faster than any currently available delivery method.
The patent pending technology allows for a more complete palatable drug delivery system that is effective and enhances the patient or user experience while intensifying flavour.
“This is a great breakthrough for us and the product line we have planned. The technology can also be utilized in our time release capsules which of course will have a slower absorption rate. We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma. “We look forward to providing additional updates in the coming weeks,” added Mr. Deuters.
The Hemp Business Journal estimates the total U.S. CBD market will grow to $2.1 billion in consumer sales by 2020.
Read more at http://www.stockhouse.com/companies/bullboard...eTmjvBQ.99
